Fennec Pharmaceuticals (FENC) Tops Q1 EPS by 6c

Fennec Pharmaceuticals (NASDAQ: FENC) reported Q1 EPS of ($0.04), $0.06 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $8.1 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.

You May Also Be Interested In

• Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
• Citi Upgrades Grupo Aeroportuario del Pacifico SAB de CV (GAPB:MM) (PAC) to Buy
• Meritage Hospitality posts Q2 loss amid restructuring charges